Agency
Acariahealth Pharmacy 13 INC
Acariahealth Pharmacy 13 INC was paid $10.27M by Medicaid between Jan 2018 and Dec 2021, across 22 billing codes. Its largest line is J0135, Injection, adalimumab, 20 mg — 37% of everything it billed.
33Billing provider infoACARIAHEALTH PHARMACY 13 INC
COMMERCE, CA 90040
COMMERCE, CA 90040
33aNPI1992786495assigned 11/10/2005
33bProvider typeHome Infusion Agency
28Total paid$10.27M
24GClaims13,382
24DCodes billed22
24AFirst – last monthJan 2018 – Dec 2021
Compared with peers
Next to other Home Infusion Agency providers in California
Rank by total paid#2 of 14
Median peer was paid$621K
This provider vs. median17×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,632 | $811K | |
| 2019 | 5,009 | $3.23M | |
| 2020 | 3,583 | $2.75M | |
| 2021 | 3,158 | $3.48M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0135 | Injection, adalimumab, 20 mg | 37% | 2,037 | 1,862 | $3.76M |
| J1438 | Injection, etanercept, 25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 24% | 1,599 | 1,469 | $2.51M |
| J3490 | Unclassified drugs | 15% | 4,072 | 3,830 | $1.58M |
| J3590 | Unclassified biologics | 14% | 1,202 | 1,123 | $1.46M |
| J1726 | Injection, hydroxyprogesterone caproate, (makena), 10 mg | 3.3% | 627 | 438 | $337K |
| J0897 | Injection, denosumab, 1 mg | 1.8% | 266 | 264 | $180K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 1.1% | 648 | 552 | $111K |
| J2941 | Injection, somatropin, 1 mg | <1% | 326 | 300 | $89K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 756 | 646 | $67K |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 20 | 14 | $57K |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 395 | 323 | $35K |
| S0028 | Injection, famotidine, 20 mg | <1% | 555 | 447 | $32K |
10 more codes
| J2357 | Injection, omalizumab, 5 mg | <1% | 29 | $32K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 121 | $18K |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 171 | $6K |
| 90715 | <1% | 223 | $4K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 252 | $2K |
| 90750 | <1% | 29 | $826.56 | |
| J1071 | Injection, testosterone cypionate, 1 mg | <1% | 13 | $359.82 |
| J9171 | Injection, docetaxel, 1 mg | <1% | 13 | $142.23 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 15 | $2.82 |
| 90707 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJENSEN, STEPHEN (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Acariahealth Pharmacy, INC. | Orlando, FL | $44K |
| 3LG Ventures INC | Fallon, NV | $39K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.